Gedatolisib (PF-05212384, PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM in cell-free assays, respectively. Phase 2.
Statement: 
->>Products covered by valid patents are not offered or supplied for commercial use. 
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1). 
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.


 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	        	 
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				         
	            	  			       	
				        